MolDrug is a company group specialized in the design and optimization of molecules through Machine Learning-powered chemoinformatics and structural bioinformatics. Our models allow for the prediction of molecular properties (QSAR) and detailed interaction analyses (molecular modelling). We work with all types of compounds, including small molecules, peptides, nanomaterials, mixtures… Our tools allow for the prediction and assessment of physicochemical, biological, pharmacological, and/or (eco)toxicological properties of substances with an array of advantages: - faster results - saving money and resources - reduce animal testing (3 Rs) - regulatory validity (REACH, CLP, ICH, BPR…) Our technology is optimized for both the chemical sector (including regulatory toxicology) and the pharma / biotech / drug development sector (including nutraceutics, cosmetics and veterinary).
Stay ahead of the competition with real-time market intelligence and actionable insights.
Disclaimer: All information contained in this database has been researched and compiled from many legitimate sources, believed to be accurate and reliable at the time of publishing. However, in view of the natural scope for human and/or mechanical error, either at source or during production, Dietary Business Intelligence (DBI) ( www.dbi360.com ) accepts no liability whatsoever for any loss or damage resulting from errors, inaccuracies or omissions affecting any part of the database. All information is provided without warranty, and DBI makes no representation of warranty of any kind as to the accuracy or completeness of any information hereto contained and strongly encourages that upon final material or product selection data points are validated with the supplier.
© Copyright 2026 Dietary Business Intelligence LLC. All Rights Reserved.
